HighTower Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.2K | Sell |
5,981
-505
| -8% | -$2.38K | ﹤0.01% | 3537 |
|
|
2025
Q1 | $29.8K | Sell |
6,486
-5,012
| -44% | -$23K | ﹤0.01% | 3440 |
|
|
2024
Q4 | $55.1K | Buy |
11,498
+6,017
| +110% | +$28.8K | ﹤0.01% | 3387 |
|
|
2024
Q3 | $26K | Sell |
5,481
-999
| -15% | -$4.74K | ﹤0.01% | 3416 |
|
|
2024
Q2 | $37K | Buy |
+6,480
| New | +$37K | ﹤0.01% | 3284 |
|
|
2024
Q1 | – | Sell |
-73,750
| Closed | -$315K | – | 3545 |
|
|
2023
Q4 | $315K | Buy |
73,750
+5,532
| +8% | +$23.6K | ﹤0.01% | 2652 |
|
|
2023
Q3 | $298K | Buy |
68,218
+55,955
| +456% | +$244K | ﹤0.01% | 2593 |
|
|
2023
Q2 | $80K | Buy |
+12,263
| New | +$80K | ﹤0.01% | 3076 |
|
|
2019
Q1 | – | Sell |
-9,539
| Closed | -$249K | – | 2245 |
|
|
2018
Q4 | $249K | Sell |
9,539
-113
| -1% | -$2.95K | ﹤0.01% | 1707 |
|
|
2018
Q3 | $221K | Buy |
+9,652
| New | +$221K | ﹤0.01% | 1896 |
|